Innovative Tissue Solutions EPISKIN SA specializes in mass-producing in vitro reconstructed human tissues, offering reliable alternatives to animal testing for cosmetic, pharmaceutical, and chemical industries, which presents opportunities for clients seeking ethically and scientifically validated testing methods.

Recent Model Launches The company has recently launched the SkinEthic RHE model and a new epithelium model, demonstrating ongoing product innovation and expansion into diverse tissue types, creating opportunities to cross-sell complementary testing and research solutions.

Training & Education EPISKIN’s new training sessions on 3D model applications and protocols open avenues to engage with research institutions and laboratories looking to adopt advanced tissue engineering techniques, enabling upsell of training and support services.

Strategic Industry Focus Partnering with major industries such as cosmetics, pharmaceuticals, and chemicals globally positions EPISKIN as a key provider of validated in vitro testing alternatives, creating potential for collaborations and expansion into new geographic markets.

Growth Opportunities With a revenue profile under 1 million USD and ongoing product validation, there is significant potential to scale sales by targeting emerging biotech and research organizations seeking innovative, validated testing models that replace traditional animal testing methods.